CLINICAL ROLE -
Manufacturers Launch Programs to Allow Greater Access to Insulin in Response to COVID-19
In response to the financial crisis driven by the coronavirus disease 2019 (COVID-19) pandemic, drug manufacturers are aiming to increase access to insulin products.
Read More